Argenx
ARGX
#527
Rank
NZ$68.79 B
Marketcap
$1,147
Share price
-2.92%
Change (1 day)
88.27%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

EPS for Argenx (ARGX)

EPS in 2023 (TTM): -$6.80

According to Argenx 's latest financial reports the company's current EPS (TTM) is -$7.45. In 2022 the company made an earnings per share (EPS) of -$23.49.

EPS history for Argenx from 2022 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$6.80-71.05%
2022-$23.49